Bloom Burton reduced their FY2025 EPS estimates for shares of AbCellera Biologics in a research note issued on Monday, March ...

But here’s the part that really matters to us value investors: Adtalem has been aggressively buying back its own shares.

Broadcom is set to report fiscal first-quarter results after the market closes Thursday, with analysts widely bullish on the ...

Telsey Advisory lowered the firm’s price target on Abercrombie & Fitch to $125 from $190 and keeps an Outperform rating on the shares. The ...